Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis
NCT05722691Phase 3Completed
- Sponsor
- Promomed
- Start
- Jun 2022
- Primary completion
- Nov 2022
- Modality
- RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Radamin Viro in coronavirus disease 2019 (COVID-19), sponsored by Promomed. Started Jun 2022; status: completed.
02
Drugs
Radamin Viro
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05722691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05722691.